The nurse is educating an adult client who has been diagnosed with adrenocortical carcinoma about the prescribed mitotane 6 g P0 in divided doses. Which statement made by the client establishes the need for further clarification? a. "If I have a trauma or go into shock, the drug is temporarily stopped."

Flumazenil is a medication that is used as an antidote for benzodiazepine overdose, including diazepam. Benzodiazepines are a class of drugs that are used to treat anxiety, insomnia, seizures, and other conditions. However, they can also be abused or taken in excessive doses, leading to overdose.

Flumazenil works by binding to the same receptors in the brain that benzodiazepines bind to, but it has the opposite effect. Flumazenil blocks the activity of benzodiazepines and can rapidly reverse the effects of an overdose, including respiratory depression, sedation, and coma.

It is important to note that flumazenil should only be used in cases of benzodiazepine overdose and should be administered under close medical supervision. Flumazenil may cause seizures in clients who are physically dependent on benzodiazepines, and it should not be used as a substitute for appropriate medical care and monitoring.

Atomoxetine is a non-stimulant medication that is used to treat attentiondeficit/hyperactivity disorder (ADHD). Unlike central nervous system (CNS) stimulants such as dextroamphetamine, dexmethylphenidate, and dextroamphetamine/amphetamine, atomoxetine does not have a high risk of abuse or dependence.

CNS stimulants like dextroamphetamine, dexmethylphenidate, and dextroamphetamine/amphetamine can be effective in treating ADHD symptoms, but they can also be abused and lead to dependence. These medications work by increasing levels of dopamine and norepinephrine in the brain, which can improve focus and attention. However, they also have the potential to be misused, particularly by individuals seeking a "high" or increased alertness.

In contrast, atomoxetine works by selectively inhibiting the reuptake of norepinephrine in the brain. This mechanism of action does not produce the same effects on dopamine levels as CNS stimulants, and it is not associated with a high risk of abuse or dependence. However, it may take several weeks for the full therapeutic effects of atomoxetine to be seen, and it may not be as effective as CNS stimulants for some individuals with ADHD.